{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:07:53Z","timestamp":1794377273566,"version":"4.9.0"},"reference-count":144,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002086","name":"Fanconi Anemia Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021790","name":"Fondation pour la Recherche sur Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["20080131921"],"award-info":[{"award-number":["20080131921"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["20080199966"],"award-info":[{"award-number":["20080199966"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["20080206797"],"award-info":[{"award-number":["20080206797"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["20090263822"],"award-info":[{"award-number":["20090263822"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["20100035286"],"award-info":[{"award-number":["20100035286"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["20100062463"],"award-info":[{"award-number":["20100062463"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["20120196300"],"award-info":[{"award-number":["20120196300"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["7547553"],"award-info":[{"award-number":["7547553"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["8298784"],"award-info":[{"award-number":["8298784"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["8916388"],"award-info":[{"award-number":["8916388"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012946","name":"Association Sorbonne Universit\u00e9","doi-asserted-by":"publisher","award":["ANR-10-IAIHU-06"],"award-info":[{"award-number":["ANR-10-IAIHU-06"]}],"id":[{"id":"10.13039\/100012946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001961","name":"AXA Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.biopsych.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T20:05:13Z","timestamp":1581537913000},"page":"745-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":666,"title":["The \u03b2-Secretase BACE1 in Alzheimer\u2019s Disease"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-8982","authenticated-orcid":false,"given":"Harald","family":"Hampel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Vassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-5819","authenticated-orcid":false,"given":"Bart","family":"De Strooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Willem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riqiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-5366","authenticated-orcid":false,"given":"Eugeen","family":"Vanmechelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8200-5336","authenticated-orcid":false,"given":"Ann","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Nistic\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-7262","authenticated-orcid":false,"given":"Bruno Pietro","family":"Imbimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Streffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Voytyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0257-9314","authenticated-orcid":false,"given":"Maarten","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Abbas","family":"Tahami Monfared","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Irizarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Albala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0095-2995","authenticated-orcid":false,"given":"Teiji","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Yarenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Lista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vergallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2020.02.001_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.biopsych.2016.12.023","article-title":"Beta-site amyloid precursor protein cleaving enzyme 1 inhibition impairs synaptic plasticity via seizure protein 6","volume":"83","author":"Zhu","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.02.001_bib2","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1523\/JNEUROSCI.4396-06.2007","article-title":"Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: Implications for Alzheimer\u2019s disease pathogenesis","volume":"27","author":"Zhao","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2020.02.001_bib4","doi-asserted-by":"crossref","first-page":"21099","DOI":"10.1074\/jbc.M002095200","article-title":"Characterization of Alzheimer\u2019s beta-secretase protein BACE: A pepsin family member with unusual properties","volume":"275","author":"Haniu","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-013-1152-3","article-title":"The Alzheimer\u2019s beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques","volume":"126","author":"Kandalepas","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","article-title":"Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer\u2019s disease","volume":"132","author":"Sadleir","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib7","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800026","article-title":"BACE2 distribution in major brain cell types and identification of novel substrates","volume":"1","author":"Voytyuk","year":"2018","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.biopsych.2020.02.001_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.12715","article-title":"Function, therapeutic potential and cell biology of BACE proteases: Current status and future prospects","volume":"130","author":"Vassar","year":"2014","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib9","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1073\/pnas.1220748110","article-title":"BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells","volume":"110","author":"Rochin","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2020.02.001_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cmet.2011.06.018","article-title":"Bace2 is a beta cell-enriched protease that regulates pancreatic beta cell function and mass","volume":"14","author":"Esterhazy","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.biopsych.2020.02.001_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","article-title":"A\u00a0pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2020.02.001_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A\u00a0mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2020.02.001_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ana.24969","article-title":"Decreased plasma \u03b2-amyloid in the Alzheimer\u2019s disease APP A673T variant carriers","volume":"82","author":"Martiskainen","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13072-018-0211-3","article-title":"DNA methylation analysis on purified neurons and glia dissects age and Alzheimer\u2019s disease-specific changes in the human cortex","volume":"11","author":"Gasparoni","year":"2018","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.biopsych.2020.02.001_bib15","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1101\/gad.2.9.1127","article-title":"Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated","volume":"2","author":"Holler","year":"1988","journal-title":"Genes Dev"},{"key":"10.1016\/j.biopsych.2020.02.001_bib16","doi-asserted-by":"crossref","first-page":"23322","DOI":"10.1074\/jbc.M101069200","article-title":"Prodomain processing of Asp1 (BACE2) is autocatalytic","volume":"276","author":"Hussain","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib17","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1038\/s41467-019-10101-7","article-title":"Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer\u2019s disease pathology and cognitive symptoms","volume":"10","author":"Li","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2020.02.001_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF02736773","article-title":"Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer\u2019s disease patient","volume":"6","author":"West","year":"1995","journal-title":"J\u00a0Mol Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2012.06.029","article-title":"Epigenetic regulation of BACE1 in Alzheimer\u2019s disease patients and in transgenic mice","volume":"220","author":"Marques","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2020.02.001_bib20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neuroscience.2015.02.054","article-title":"Galangin-induced down-regulation of BACE1 by epigenetic mechanisms in SH-SY5Y cells","volume":"294","author":"Zeng","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2020.02.001_bib21","article-title":"Histone acetyltransferase p300 mediates histone acetylation of PS1 and BACE1 in a cellular model of Alzheimer\u2019s disease","volume":"9","author":"Lu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2020.02.001_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pneurobio.2006.06.001","article-title":"Transcriptional and translational regulation of BACE1 expression\u2014Implications for Alzheimer\u2019s disease","volume":"79","author":"Rossner","year":"2006","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/iub.1099","article-title":"Transcriptional and post-transcriptional regulation of \u03b2-secretase","volume":"64","author":"Tamagno","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopsych.2020.02.001_bib24","first-page":"365","article-title":"MicroRNA (miRNA) speciation in Alzheimer\u2019s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)","volume":"3","author":"Alexandrov","year":"2012","journal-title":"Int J Biochem Mol Biol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib25","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression","volume":"105","author":"Hebert","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2020.02.001_bib26","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1096\/fj.201801846R","article-title":"Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer\u2019s disease","volume":"33","author":"Qian","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.biopsych.2020.02.001_bib27","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The expression of microRNA miR-107 decreases early in Alzheimer\u2019s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib28","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1074\/jbc.M113.518241","article-title":"MicroRNA-339-5p down-regulates protein expression of \u03b2-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects","volume":"289","author":"Long","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib29","doi-asserted-by":"crossref","first-page":"16739","DOI":"10.1074\/jbc.M009361200","article-title":"Characterization of the glycosylation profiles of Alzheimer\u2019s beta-secretase protein Asp-2 expressed in a variety of cell lines","volume":"276","author":"Charlwood","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15252\/emmm.201404438","article-title":"An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer\u2019s disease","volume":"7","author":"Kizuka","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.biopsych.2020.02.001_bib31","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1073\/pnas.1800498115","article-title":"BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer\u2019s disease","volume":"115","author":"Bao","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2020.02.001_bib32","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1074\/jbc.M808920200","article-title":"Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts","volume":"284","author":"Vetrivel","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib33","doi-asserted-by":"crossref","first-page":"14634","DOI":"10.1074\/jbc.M011116200","article-title":"Phosphorylation regulates intracellular trafficking of beta-secretase","volume":"276","author":"Walter","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/mcne.2001.1065","article-title":"The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A\u03b2","volume":"19","author":"Pastorino","year":"2002","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib35","article-title":"Enhancement of BACE1 activity by p25\/Cdk5-mediated phosphorylation in Alzheimer\u2019s disease","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2020.02.001_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/BJ20070040","article-title":"A\u00a0reversible form of lysine acetylation in the ER and Golgi lumen controls the molecular stabilization of BACE1","volume":"407","author":"Costantini","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.biopsych.2020.02.001_bib37","doi-asserted-by":"crossref","first-page":"24108","DOI":"10.1074\/jbc.M109.092742","article-title":"Ubiquitin regulates GGA3-mediated degradation of BACE1","volume":"285","author":"Kang","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib38","doi-asserted-by":"crossref","first-page":"42867","DOI":"10.1074\/jbc.M112.407072","article-title":"BACE1 protein endocytosis and trafficking are differentially regulated by ubiquitination at lysine 501 and the Di-leucine motif in the carboxyl terminus","volume":"287","author":"Kang","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib39","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1471-4159.2003.01597.x","article-title":"Employing a superior BACE1 cleavage sequence to probe cellular APP processing","volume":"84","author":"Tomasselli","year":"2003","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib40","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1021\/bi025926t","article-title":"Specificity of memapsin 1 and its implications on the design of memapsin 2 (beta-secretase) inhibitor selectivity","volume":"41","author":"Turner","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopsych.2020.02.001_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/85059","article-title":"Mice deficient in BACE1, the Alzheimer\u2019s beta-secretase, have normal phenotype and abolished beta-amyloid generation","volume":"4","author":"Luo","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib42","doi-asserted-by":"crossref","first-page":"30797","DOI":"10.1074\/jbc.M505249200","article-title":"Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice","volume":"280","author":"Dominguez","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1044-7431(03)00227-6","article-title":"BACE1 (beta-secretase) transgenic and knockout mice: Identification of neurochemical deficits and behavioral changes","volume":"24","author":"Harrison","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib44","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.1168979","article-title":"A\u00a0recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis","volume":"323","author":"Di Fede","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2020.02.001_bib45","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/359322a0","article-title":"Amyloid beta-peptide is produced by cultured cells during normal metabolism","volume":"359","author":"Haass","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2020.02.001_bib46","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1074\/jbc.M116.766584","article-title":"Autophagy-mediated regulation of BACE1 protein trafficking and degradation","volume":"292","author":"Feng","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature14864","article-title":"\u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus","volume":"526","author":"Willem","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2020.02.001_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0169-328X(95)00328-P","article-title":"Selective localization of amyloid precursor-like protein 1 in the cerebral cortex postsynaptic density","volume":"32","author":"Kim","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.biopsych.2020.02.001_bib49","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3233\/JAD-132030","article-title":"Synaptic and sub-synaptic localization of amyloid-\u03b2 protein precursor in the rat hippocampus","volume":"40","author":"Rodrigues","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2020.02.001_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao4827","article-title":"Secreted amyloid-\u03b2 precursor protein functions as a GABABR1a ligand to modulate synaptic transmission","volume":"363","author":"Rice","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2020.02.001_bib51","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1074\/jbc.M900141200","article-title":"The effects of amyloid precursor protein on postsynaptic composition and activity","volume":"284","author":"Hoe","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.1252884","article-title":"Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins","volume":"344","author":"Wilhelm","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2020.02.001_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00221-011-2939-x","article-title":"Role of APP for dendritic spine formation and stability","volume":"217","author":"Jung","year":"2012","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.biopsych.2020.02.001_bib54","doi-asserted-by":"crossref","first-page":"13314","DOI":"10.1523\/JNEUROSCI.2848-14.2014","article-title":"The amyloid precursor protein controls adult hippocampal neurogenesis through GABAergic interneurons","volume":"34","author":"Wang","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(98)00410-2","article-title":"Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein","volume":"90","author":"Dawson","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2020.02.001_bib56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0028-3908(98)00204-4","article-title":"Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein","volume":"38","author":"Seabrook","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2020.02.001_bib57","doi-asserted-by":"crossref","first-page":"15660","DOI":"10.1523\/JNEUROSCI.4104-09.2009","article-title":"Amyloid precursor protein regulates Cav1.2 L-type calcium channel levels and function to influence GABAergic short-term plasticity","volume":"29","author":"Yang","year":"2009","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib58","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1523\/JNEUROSCI.5171-13.2014","article-title":"Genetic suppression of transgenic APP rescues hypersynchronous network activity in a mouse model of Alzeimer\u2019s disease","volume":"34","author":"Born","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2051-5960-2-36","article-title":"Comparative analysis of single and combined APP\/APLP knockouts reveals reduced spine density in APP-KO mice that is prevented by APPs\u03b1 expression","volume":"2","author":"Weyer","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.biopsych.2020.02.001_bib60","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1523\/JNEUROSCI.1026-07.2007","article-title":"The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice","volume":"27","author":"Ring","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00401-014-1368-x","article-title":"Acute function of secreted amyloid precursor protein fragment APPs\u03b1 in synaptic plasticity","volume":"129","author":"Hick","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","article-title":"Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory","volume":"70","author":"Turner","year":"2003","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib63","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/s41467-019-09164-3","article-title":"Complex formation of APP with GABAB receptors links axonal trafficking to amyloidogenic processing","volume":"10","author":"Dinamarca","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2020.02.001_bib64","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/hmg\/10.12.1317","article-title":"BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: Implications for Alzheimer\u2019s disease therapeutics","volume":"10","author":"Roberds","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biopsych.2020.02.001_bib65","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neurobiolaging.2007.01.002","article-title":"BACE1 gene deletion: Impact on behavioral function in a model of Alzheimer\u2019s disease","volume":"29","author":"Kobayashi","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2020.02.001_bib66","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1073\/pnas.0710373105","article-title":"Alteration of BACE1-dependent NRG1\/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice","volume":"105","author":"Savonenko","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2020.02.001_bib67","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/emmm.201101084","article-title":"\u03b2-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment","volume":"4","author":"Cai","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.biopsych.2020.02.001_bib68","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/emboj.2012.173","article-title":"Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons","volume":"31","author":"Kuhn","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.biopsych.2020.02.001_bib69","doi-asserted-by":"crossref","first-page":"25927","DOI":"10.1074\/jbc.M112.377465","article-title":"The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in\u00a0vivo","volume":"287","author":"Zhou","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib70","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.1132341","article-title":"Control of peripheral nerve myelination by the beta-secretase BACE1","volume":"314","author":"Willem","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2020.02.001_bib71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13024-016-0134-z","article-title":"Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons","volume":"11","author":"Pigoni","year":"2016","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2020.02.001_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5620","article-title":"Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice","volume":"10","author":"Ou-Yang","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2020.02.001_bib73","doi-asserted-by":"crossref","first-page":"13667","DOI":"10.1523\/JNEUROSCI.2888-07.2007","article-title":"Close homolog of L1 and neuropilin 1 mediate guidance of thalamocortical axons at the ventral telencephalon","volume":"27","author":"Wright","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14283\/jpad.2019.3","article-title":"Editorial: Implications for BACE1 inhibitor clinical trials: Adult conditional BACE1 knockout mice exhibit axonal organization defects in the hippocampus","volume":"6","author":"Vassar","year":"2019","journal-title":"J\u00a0Prev Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2020.02.001_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147254","article-title":"Identification of human islet amyloid polypeptide as a BACE2 substrate","volume":"11","author":"Rulifson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2020.02.001_bib76","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1007\/s00018-017-2505-1","article-title":"BACE2 suppression promotes \u03b2-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression","volume":"74","author":"Alcarraz-Vizan","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajpath.2011.09.034","article-title":"BACE2 expression increases in human neurodegenerative disease","volume":"180","author":"Holler","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib78","doi-asserted-by":"crossref","first-page":"9640","DOI":"10.1038\/s41598-019-45896-4","article-title":"Common BACE2 polymorphisms are associated with altered risk for Alzheimer\u2019s disease and CSF amyloid biomarkers in APOE \u03b54 non-carriers","volume":"9","author":"Huentelman","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2020.02.001_bib79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2010-1367","article-title":"BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology","volume":"20","author":"Mulder","year":"2010","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2020.02.001_bib80","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archpsyc.64.6.718","article-title":"Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment","volume":"64","author":"Zhong","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2020.02.001_bib81","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awn034","article-title":"Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer\u2019s disease","volume":"131","author":"Ewers","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2020.02.001_bib82","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/jnr.23122","article-title":"Characterization of plasma \u03b2-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer\u2019s disease","volume":"90","author":"Wu","year":"2012","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.biopsych.2020.02.001_bib83","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","article-title":"Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease","volume":"65","author":"Zetterberg","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib84","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-2011-091153","article-title":"Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer\u2019s disease","volume":"25","author":"Ewers","year":"2011","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2020.02.001_bib85","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer\u2019s fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib86","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jalz.2019.07.001","article-title":"Brain A\u03b2 load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2020.02.001_bib87","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopsych.2017.02.007","article-title":"Increased plasma beta-secretase 1 may predict conversion to Alzheimer\u2019s disease dementia in individuals with mild cognitive impairment","volume":"83","author":"Shen","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.02.001_bib88","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3233\/JAD-150795","article-title":"Platelet membrane \u03b2-secretase activity in mild cognitive impairment and conversion to dementia: A longitudinal study","volume":"49","author":"McGuinness","year":"2016","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2020.02.001_bib89","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11064-013-1039-7","article-title":"Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI)","volume":"38","author":"Bermejo-Bescos","year":"2013","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2020.02.001_bib90","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3233\/JAD-142778","article-title":"Soluble BACE-1 activity and sA\u03b2PP\u03b2 concentrations in Alzheimer\u2019s disease and age-matched healthy control cerebrospinal fluid from the Alzheimer\u2019s Disease Neuroimaging Initiative-1 baseline cohort","volume":"46","author":"Savage","year":"2015","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2020.02.001_bib91","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1016\/j.jalz.2013.09.006","article-title":"Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer\u2019s disease","volume":"10","author":"Perneczky","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2020.02.001_bib92","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.clinbiochem.2008.04.022","article-title":"Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer\u2019s subjects","volume":"41","author":"Wu","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib93","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000488481","article-title":"Cerebrospinal fluid BACE1 activity and sA\u03b2PP\u03b2 as biomarker candidates of Alzheimer\u2019s disease","volume":"45","author":"Alexopoulos","year":"2018","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.biopsych.2020.02.001_bib94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12017-012-8171-4","article-title":"Cerebrospinal fluid profiles of amyloid \u03b2-related biomarkers in Alzheimer\u2019s disease","volume":"14","author":"Rosen","year":"2012","journal-title":"Neuromolecular Med"},{"issue":"suppl 2","key":"10.1016\/j.biopsych.2020.02.001_bib95","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/JAD-2011-110017","article-title":"BACE1 as a potential biomarker for Alzheimer\u2019s disease","volume":"24","author":"Decourt","year":"2011","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2020.02.001_bib96","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2020.02.001_bib97","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMc1813435","article-title":"Preliminary results of a trial of atabecestat in preclinical Alzheimer\u2019s disease","volume":"380","author":"Henley","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2020.02.001_bib98","author":"Strobel"},{"key":"10.1016\/j.biopsych.2020.02.001_bib99","first-page":"S37","article-title":"Results from the phase 2 NAVIGATE-AD clinical trial evaluating LY3202626 BACE inhibitor in patients with mild Alzheimer\u2019s disease dementia","author":"Albert C Lo","year":"2018","journal-title":"CTAD (Clinical Trials on Alzheimer's Disease) 2018, Abstract LB1"},{"key":"10.1016\/j.biopsych.2020.02.001_bib100","series-title":"Statement on discontinuation of BACE 1 inhibitor CNP520 in the Alzheimer\u2019s Prevention Initiative Generation Study 1","year":"2019"},{"key":"10.1016\/j.biopsych.2020.02.001_bib101","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/nn.2433","article-title":"Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses","volume":"12","author":"Abramov","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib102","doi-asserted-by":"crossref","first-page":"12684","DOI":"10.1111\/acel.12684","article-title":"Amyloid beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells","volume":"17","author":"Zimbone","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.biopsych.2020.02.001_bib103","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pneurobio.2018.12.004","article-title":"Pivotal role of carnosine in the modulation of brain cells activity: Multimodal mechanism of action and therapeutic potential in neurodegenerative disorders","volume":"175","author":"Caruso","year":"2019","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib104","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2020.02.001_bib105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of amyloid and tau with cognition in preclinical Alzheimer disease: A longitudinal study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib106","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1093\/brain\/awz268","article-title":"The bivariate distribution of amyloid-\u03b2 and tau: Relationship with established neurocognitive clinical syndromes","volume":"142","author":"Jack","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2020.02.001_bib107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib108","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.biopsych.2018.04.022","article-title":"Consequences of pharmacological BACE inhibition on synaptic structure and function","volume":"84","author":"Zhu","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.02.001_bib109","article-title":"Chronic nicrodose lithium treatment prevented memory loss and neurohistopathological changes in a transgenic mouse model of Alzheimer\u2019s disease","volume":"10","author":"Nunes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2020.02.001_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.169","article-title":"BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology","volume":"7","author":"Wilson","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2020.02.001_bib111","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-190197","article-title":"Lithium as a treatment for Alzheimer\u2019s disease: The systems pharmacology perspective","volume":"69","author":"Hampel","year":"2019","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2020.02.001_bib112","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jnr.21858","article-title":"Inhibition by KMI-574 leads to dislocalization of BACE1 from lipid rafts","volume":"87","author":"Ebina","year":"2009","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.biopsych.2020.02.001_bib113","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer\u2019s disease: An appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biopsych.2020.02.001_bib114","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2020.02.001_bib115","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","article-title":"The \u201cArctic\u201d APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced Abeta protofibril formation","volume":"4","author":"Nilsberth","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib116","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.21321","article-title":"A\u00a0new amyloid beta variant favoring oligomerization in Alzheimer\u2019s-type dementia","volume":"63","author":"Tomiyama","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib117","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.0b013e31825fdf18","article-title":"Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers","volume":"79","author":"Scholl","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2020.02.001_bib118","doi-asserted-by":"crossref","first-page":"14411","DOI":"10.1523\/JNEUROSCI.3537-10.2010","article-title":"Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils","volume":"30","author":"O\u2019Nuallain","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib119","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2020.02.001_bib120","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2020.02.001_bib121","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib122","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2020.02.001_bib123","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archneurol.2011.202","article-title":"Divergent network connectivity changes in healthy APOE \u03b54 carriers: Disinhibition or compensation?","volume":"68","author":"Seeley","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib124","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1523\/JNEUROSCI.1230-11.2011","article-title":"Increased hippocampal default mode synchronization during rest in middle-aged and elderly APOE \u03b54 carriers: Relationships with memory performance","volume":"31","author":"Westlye","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroimage.2009.12.008","article-title":"Effects of aging on default mode network activity in resting state fMRI: Does the method of analysis matter?","volume":"51","author":"Koch","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.biopsych.2020.02.001_bib126","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nn.4502","article-title":"Network neuroscience","volume":"20","author":"Bassett","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib127","doi-asserted-by":"crossref","first-page":"101662","DOI":"10.1016\/j.pneurobio.2019.101662","article-title":"Time for the systems-level integration of aging: Resilience enhancing strategies to prevent Alzheimer\u2019s disease","volume":"181","author":"Hampel","year":"2019","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib128","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/brain\/awy008","article-title":"Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer\u2019s disease","volume":"141","author":"Franzmeier","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2020.02.001_bib129","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jalz.2019.03.006","article-title":"Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer\u2019s disease","volume":"15","author":"Chiesa","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2020.02.001_bib130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neurobiolaging.2019.12.017","article-title":"Association of brain network dynamics with plasma biomarkers in subjective memory complainers","volume":"88","author":"Chiesa","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2020.02.001_bib131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13195-016-0208-8","article-title":"The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer\u2019s disease","volume":"8","author":"Ohrfelt","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.biopsych.2020.02.001_bib132","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2010.09.073","article-title":"Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer\u2019s disease","volume":"1362","author":"Thorsell","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2020.02.001_bib133","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jalz.2018.01.012","article-title":"Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer\u2019s disease","volume":"14","author":"Sutphen","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2020.02.001_bib134","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cell.2014.10.016","article-title":"Lessons from a failed \u03b3-secretase Alzheimer trial","volume":"159","author":"De Strooper","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2020.02.001_bib135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2010-091603","article-title":"MiR-107 is reduced in Alzheimer\u2019s disease brain neocortex: Validation study","volume":"21","author":"Nelson","year":"2010","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2020.02.001_bib136","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2350-13-35","article-title":"Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10","volume":"13","author":"Augustin","year":"2012","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.biopsych.2020.02.001_bib137","first-page":"1565","article-title":"Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer\u2019s disease","volume":"8","author":"Lei","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.biopsych.2020.02.001_bib138","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2011.04.035","article-title":"miR-29c regulates BACE1 protein expression","volume":"1395","author":"Zong","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2020.02.001_bib139","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/jnc.13507","article-title":"miR-186 is decreased in aged brain and suppresses BACE1 expression","volume":"137","author":"Kim","year":"2016","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib140","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.brainresbull.2012.05.018","article-title":"MicroRNA-195 downregulates Alzheimer\u2019s disease amyloid-\u03b2 production by targeting BACE1","volume":"88","author":"Zhu","year":"2012","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2020.02.001_bib141","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxlet.2011.11.032","article-title":"The miR-124 regulates the expression of BACE1\/\u03b2-secretase correlated with cell death in Alzheimer\u2019s disease","volume":"209","author":"Fang","year":"2012","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.biopsych.2020.02.001_bib142","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1074\/jbc.M807530200","article-title":"MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1","volume":"284","author":"Boissonneault","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2020.02.001_bib143","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tins.2016.01.003","article-title":"BACE1 physiological functions may limit its use as therapeutic target for Alzheimer\u2019s disease","volume":"39","author":"Bar\u00e3o","year":"2016","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2020.02.001_bib144","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40263-019-00613-7","article-title":"A\u00a0close look at BACE1 inhibitors for Alzheimer\u2019s disease treatment","volume":"33","author":"Das","year":"2019","journal-title":"CNS Drugs"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322320300639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322320300639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:04:40Z","timestamp":1762099480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322320300639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":144,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0006322320300639"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.02.001","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u03b2-Secretase BACE1 in Alzheimer\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}